Increased protein excretion, including albumin, by children of patients with urolithiasis

1Barker DJ, Morris JA, Margetts BM. Diet and renal stones in 72 areas in England and Wales. Br J Urol. 1988; 62:315-8.319135410.1111/j.1464-410X.1988.tb04355.xBarkerDJMorrisJAMargettsBMDiet and renal stones in 72 areas in England and WalesBr J Urol19886231583191354Search in Google Scholar

2Muslumanoglu AY, Binbay M, Yuruk E, Akman T, Tepeler A, Esen T, et al. Updated epidemiologic study of urolithiasis in Turkey. I: Changing characteristics of urolithiasis. Urol Res. 2011; 39:309-14.2116164610.1007/s00240-010-0346-6MuslumanogluAYBinbayMYurukEAkmanTTepelerAEsenTet alUpdated epidemiologic study of urolithiasis in Turkey. I: Changing characteristics of urolithiasisUrol Res2011393091421161646Search in Google Scholar

3Seitz C, Fajkovic H. Epidemiological gender-specific aspects in urolithiasis. World J Urol. 2013; 31:1087-92.10.1007/s00345-013-1140-123942884SeitzCFajkovicHEpidemiological gender-specific aspects in urolithiasisWorld J Urol20133110879223942884Open DOISearch in Google Scholar

4Yanagawa M, Kawamura J, Onishi T, Soga N, Kameda K, Sriboonlue P, et al. Incidence of urolithiasis in northeast Thailand. Int J Urol. 1997; 4:537-40.10.1111/j.1442-2042.1997.tb00304.x9477179YanagawaMKawamuraJOnishiTSogaNKamedaK iboonlue PSret alIncidence of urolithiasis in northeast ThailandInt J Urol19974537409477179Open DOISearch in Google Scholar

5Sritippayawan S, Borvornpadungkitti S, Paemanee A, Predanon C, Susaengrat W, Chuawattana D, et al. Evidence suggesting a genetic contribution to kidney stone in northeastern Thai population. Urol Res. 2009; 37:141-6.1938762710.1007/s00240-009-0189-1SritippayawanSBorvornpadungkittiSPaemaneeAPredanonCSusaengratWChuawattanaDet alEvidence suggesting a genetic contribution to kidney stone in northeastern Thai populationUrol Res200937141619387627Search in Google Scholar

6Stitchantrakul W, Kochakarn W, Ruangraksa C, Domrongkitchaiporn S. Urinary risk factors for recurrent calcium stone formation in Thai stone formers. J Med Assoc Thai. 2007; 90:688-98.17487123StitchantrakulWKochakarnWRuangraksaCDomrongkitchaipornSUrinary risk factors for recurrent calcium stone formation in Thai stone formersJ Med Assoc Thai20079068898Search in Google Scholar

7Chen S, Gao X, Sun Y, Xu C, Wang L, Zhou T. Analysis of HK-2 cells exposed to oxalate and calcium oxalate crystals: proteomic insights into the molecular mechanisms of renal injury and stone formation. Urol Res. 2010; 38:7-15.10.1007/s00240-009-0226-019862510ChenSGaoXSunYXuCWangLZhouTAnalysis of HK-2 cells exposed to oxalate and calcium oxalate crystals: proteomic insights into the molecular mechanisms of renal injury and stone formationUrol Res20103871519862510Open DOISearch in Google Scholar

8Aminian M, Nabatchian F, Vaisi-Raygani A, Torabi M. Mechanism of Coomassie Brilliant Blue G-250 binding to cetyltrimethylammonium bromide: an interference with the Bradford assay. Anal Biochem. 2013; 434: 287-91.2321956510.1016/j.ab.2012.11.014AminianMNabatchianFVaisi-RayganiATorabiMMechanism of Coomassie Brilliant Blue G-250 binding to cetyltrimethylammonium bromide: an interference with the Bradford assayAnal Biochem20134342879123219565Search in Google Scholar

9Wenrich BR, Trumbo TA. Interaction of nucleic acids with Coomassie Blue G-250 in the Bradford assay. Anal Biochem. 2012; 428:93-5.10.1016/j.ab.2012.06.01422743308WenrichBRTrumboTAInteraction of nucleic acids with Coomassie Blue G-250 in the Bradford assayAnal Biochem201242893522743308Open DOISearch in Google Scholar

10Fu S, Sun Y, Luo L, Ye P. Relationship of arterial compliance and blood pressure with microalbuminuria and mildly decreased glomerular filtration rate: a Chinese community-based analysis. PloS one. 2014; 9:e101013.10.1371/journal.pone.010101324963717FuSSunYLuoLYePRelationship of arterial compliance and blood pressure with microalbuminuria and mildly decreased glomerular filtration rate: a Chinese community-based analysisPloS one20149e101013407104724963717Open DOISearch in Google Scholar

11Triki S, Fekih O, Hellara I, Neffati F, Douki W, Hamda KB, et al. Association between serum cystatin C levels and cardiovascular disease in type 2 diabetic patients. Ann Bio Clin. 2013; 71:438-42.TrikiSFekihOHellaraINeffatiFDoukiWHamdaKBet alAssociation between serum cystatin C levels and cardiovascular disease in type 2 diabetic patientsAnn Bio Clin2013714384210.1684/abc.2013.085723906571Search in Google Scholar

12Somparn P, Hirankarn N, Leelahavanichkul A, Khovidhunkit W, Thongboonkerd V, Avihingsanon Y. Urinary proteomics revealed prostaglandin H D-2 isomerase, not Zn-α2-glycoprotein, as a biomarker for active lupus nephritis. J Proteomics. 2012; 75: 3240-7.10.1016/j.jprot.2012.03.034SomparnPHirankarnNLeelahavanichkulAKhovidhunkitWThongboonkerdVAvihingsanonYUrinary proteomics revealed prostaglandin H D-2 isomerase, not Zn-α2-glycoprotein, as a biomarker for active lupus nephritisJ Proteomics2012753240722498882Open DOISearch in Google Scholar

13Mishra S, Sinha L, Ganesamoni R, Ganpule A, Sabnis RB, Desai M. Renal deterioration index: preoperative prognostic model for renal functional outcome after treatment of bilateral obstructive urolithiasis in patients with chronic kidney disease. J Endo. 2013; 27:1405-10.MishraSSinhaLGanesamoniRGanpuleASabnisRBDesaiMRenal deterioration index: preoperative prognostic model for renal functional outcome after treatment of bilateral obstructive urolithiasis in patients with chronic kidney diseaseJ Endo20132714051010.1089/end.2012.045623537205Search in Google Scholar

14Schwille PO, Schmiedl A, Manoharan M, Wipplinger J. Idiopathic Recurrent Calcium Urolithiasis (IRCU): pathophysiology evaluated in light of oxidative metabolism, without and with variation of several biomarkers in fasting urine and plasma—a comparison of stone-free and -bearing male patients, emphasizing mineral, acid-base, blood pressure and protein status. Eur J Med Res. 2011; 16:349-66.21813378SchwillePOSchmiedlAManoharanMWipplingerJIdiopathic Recurrent Calcium Urolithiasis (IRCU): pathophysiology evaluated in light of oxidative metabolism, without and with variation of several biomarkers in fasting urine and plasma—a comparison of stone-free and -bearing male patients, emphasizing mineral, acid-base, blood pressure and protein statusEur J Med Res2011163496610.1186/2047-783X-16-8-349335198721813378Search in Google Scholar

15Arrabal-Polo MA, Arrabal-Martin M, Giron-Prieto MS, Orgaz-Molina J, Quesada-Charneco M, Lopez-Ruiz A, et al. Association of severe calcium lithogenic activity and bone remodeling markers. Urol. 2013; 82:16-21.10.1016/j.urology.2013.02.035Arrabal-PoloMAArrabal-MartinMGiron-PrietoMSOrgaz-MolinaJQuesada-CharnecoMLopez-RuizAet alAssociation of severe calcium lithogenic activity and bone remodeling markersUrol201382162123601442Open DOISearch in Google Scholar

16Salama RH, Alghasham A, Mostafa MS, El-Moniem AE. Bone morphogenetic protein-2 will be a novel biochemical marker in urinary tract infections and stone formation. Clin Biochem. 2012; 45:766-9.10.1016/j.clinbiochem.2012.04.005SalamaRHAlghashamAMostafaMSEl-MoniemAEBone morphogenetic protein-2 will be a novel biochemical marker in urinary tract infections and stone formationClin Biochem201245766922542719Open DOISearch in Google Scholar

17Tsuji H, Tohru U, Hirotsugu U, Masanori I, Yuji H, Takashi K. Urinary concentration of osteopontin and association with urinary supersaturation and crystal formation. Int J Urol. 2007; 14:630-4.10.1111/j.1442-2042.2007.01783.x17645608TsujiHTohruUHirotsuguUMasanoriIYujiHTakashiKUrinary concentration of osteopontin and association with urinary supersaturation and crystal formationInt J Urol200714630417645608Open DOISearch in Google Scholar

18Mushtaq S, Siddiqui AA, Naqvi ZA, Rattani A, Talati J, Palmberg C, et al. Identification of myeloperoxidase, α-defensin and calgranulin in calcium oxalate renal stones. Clin Chim Acta. 2007; 384:41-7.1761086010.1016/j.cca.2007.05.015MushtaqSSiddiquiAANaqviZARattaniATalatiJPalmbergCet alIdentification of myeloperoxidase, α-defensin and calgranulin in calcium oxalate renal stonesClin Chim Acta200738441717610860Search in Google Scholar

19Zhu W, Liu M, Wang GC, Che JP, Xu YF, Peng B, et al. Urinary neutrophil gelatinase-associated lipocalin, a biomarker for systemic inflammatory response syndrome in patients with nephrolithiasis. J Surg Res. 2014; 187:237-43.10.1016/j.jss.2013.09.03624239146ZhuWLiuMWangGCCheJPXuYFPengBet alUrinary neutrophil gelatinase-associated lipocalin, a biomarker for systemic inflammatory response syndrome in patients with nephrolithiasisJ Surg Res20141872374324239146Open DOISearch in Google Scholar

20Fahmy N, Sener A, Sabbisetti V, Nott L, Lang RM, Welk BK, et al. Urinary expression of novel tissue markers of kidney injury after ureteroscopy, shockwave lithotripsy, and in normal healthy controls. J Endo. 2013; 27:1455-62.FahmyNSenerASabbisettiVNottLLangRMWelkBKet alUrinary expression of novel tissue markers of kidney injury after ureteroscopy, shockwave lithotripsy, and in normal healthy controlsJ Endo20132714556210.1089/end.2013.0188399708824180435Search in Google Scholar

21Horuz R, Goktas C, Cetinel CA, Akca O, Aydin H, Ekici ID, et al. Role of TNF-associated cytokines in renal tubular cell apoptosis induced by hyperoxaluria. Urolithiasis. 2013; 41:197-203.10.1007/s00240-013-0559-623595894HoruzRGoktasCCetinelCAAkcaOAydinHEkiciIDet alRole of TNF-associated cytokines in renal tubular cell apoptosis induced by hyperoxaluriaUrolithiasis20134119720323595894Open DOISearch in Google Scholar

22Suen JL, Liu CC, Lin YS, Tsai YF, Juo SH, Chou YH. Urinary chemokines/cytokines are elevated in patients with urolithiasis. Urol Res. 2010; 38:81-7.10.1007/s00240-010-0260-y20204339SuenJLLiuCCLinYSTsaiYFJuoSHChouYHUrinary chemokines/cytokines are elevated in patients with urolithiasisUrol Res20103881720204339Open DOISearch in Google Scholar

23Manoharan M, Schwille PO. Oxypurines, protein, glucose and the functional state of blood vasculature are markers of renal calcium stone-forming processes? Observations in men with idiopathic recurrent calcium urolithiasis. Clin Chem Lab Med. 2002; 40:266-77.12005217ManoharanMSchwillePOOxypurines, protein, glucose and the functional state of blood vasculature are markers of renal calcium stone-forming processes? Observations in men with idiopathic recurrent calcium urolithiasisClin Chem Lab Med2002402667710.1515/CCLM.2002.04312005217Search in Google Scholar

24Pourmand G, Nasseh H, Sarrafnejad A, Mojtahedi A, Mehrsai A, Alamdari DH, et al. Comparison of urinary proteins in calcium stone formers and healthy individuals: a case-control study. Urol Int. 2006; 76: 163-8.1649322010.1159/000090882PourmandGNassehHSarrafnejadAMojtahediAMehrsaiAAlamdariDHet alComparison of urinary proteins in calcium stone formers and healthy individuals: a case-control studyUrol Int200676163816493220Search in Google Scholar

25Walton RC, Kavanagh JP, Heywood BR, Rao PN. The association of different urinary proteins with calcium oxalate hydromorphs. Evidence for nonspecific interactions. Biochim Biophys Acta. 2005; 1723:175-83.10.1016/j.bbagen.2005.02.014WaltonRCKavanaghJPHeywoodBRRaoPNThe association of different urinary proteins with calcium oxalate hydromorphs. Evidence for nonspecific interactionsBiochim Biophys Acta200517231758315863356Open DOISearch in Google Scholar

26Bergsland KJ, Kelly JK, Coe BJ, Coe FL. Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers. Am J Physiol Renal Physiol. 2006; 291:F530-6.1662217610.1152/ajprenal.00370.2005BergslandKJKellyJKCoeBJCoeFLUrine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formersAm J Physiol Renal Physiol2006291F530616622176Search in Google Scholar

27Thongboonkerd V. Proteomics and kidney stone disease. Contrib Nephrol. 2008; 160:142-58.18401167ThongboonkerdVProteomics and kidney stone diseaseContrib Nephrol20081601425810.1159/00012597218401167Search in Google Scholar

28Merchant ML, Cummins TD, Wilkey DW, Salyer SA, Powell DW, Klein JB, et al. Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. Am J Physiol Renal Physiol. 2008; 295:F1254-8.10.1152/ajprenal.00134.200818701630MerchantMLCumminsTDWilkeyDWSalyerSAPowellDWKleinJBet alProteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formationAm J Physiol Renal Physiol2008295F12548257613618701630Open DOISearch in Google Scholar

29Parsons CL, Rajasekaran M, Arsanjani AH, Chenoweth M, Stein P. Role of sialic acid in urinary cytoprotective activity of Tamm-Horsfall protein. Urology. 2007; 69:577-81.10.1016/j.urology.2006.12.02617382182ParsonsCLRajasekaranMArsanjaniAHChenowethMSteinPRole of sialic acid in urinary cytoprotective activity of Tamm-Horsfall proteinUrology2007695778117382182Open DOISearch in Google Scholar

30Viswanathan P, Rimer JD, Kolbach AM, Ward MD, Kleinman J G, Wesson JA. Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein. Urol Res. 2011; 39:269-82.2122923910.1007/s00240-010-0353-7ViswanathanPRimerJDKolbachAMWardMDKleinmanJGWessonJACalcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall proteinUrol Res20113926982311709621229239Search in Google Scholar

31Webber D, Radcliffe CM, Royle L, Tobiasen G, Merry AH, Rodgers AL, et al. Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation. FEBS. 2006; 273:3024-37.10.1111/j.1742-4658.2006.05314.xWebberDRadcliffeCMRoyleLTobiasenGMerryAHRodgersALet alSialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formationFEBS200627330243716817853Open DOISearch in Google Scholar

32Jaggi M, Nakagawa Y, Zipperle L, Hess B. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Urol Res. 2007; 35:55-62.1734507710.1007/s00240-007-0083-7JaggiMNakagawaYZipperleLHessBTamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and functionUrol Res200735556217345077Search in Google Scholar

33Gudbjartsson DF, Holm H, Indridason OS, Thorleifsson G, Edvardsson V, Sulem P, et al. Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases. PLoS Genetics. 2010; 6:e1001039.2068665110.1371/journal.pgen.1001039GudbjartssonDFHolmHIndridasonOSThorleifssonGEdvardssonVSulemPet alAssociation of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseasesPLoS Genetics20106e1001039291238620686651Search in Google Scholar